- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Cancer Stem Cells in Triple-Negative Breast Cancer
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 7, Pages 965
Publisher
MDPI AG
Online
2019-07-10
DOI
10.3390/cancers11070965
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of USP2 eliminates cancer stem cells and enhances TNBC responsiveness to chemotherapy
- (2019) Jiabei He et al. Cell Death & Disease
- Connexins in cancer: bridging the gap to the clinic
- (2019) Trond Aasen et al. ONCOGENE
- Cell growth inhibition and apoptosis in breast cancer cells induced by anti-FZD7 scFvs: involvement of bioinformatics-based design of novel epitopes
- (2018) Neda Zarei et al. BREAST CANCER RESEARCH AND TREATMENT
- Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK/STAT3 signaling pathway in breast cancer
- (2018) Xianmin Mu et al. CELL CYCLE
- Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy
- (2018) Tina Cascone et al. Cell Metabolism
- Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling
- (2018) Ming Luo et al. Cell Metabolism
- JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance
- (2018) Tianyi Wang et al. Cell Metabolism
- Metabolic Barriers to T Cell Function in Tumors
- (2018) Ayaka Sugiura et al. JOURNAL OF IMMUNOLOGY
- An inhibitor of oxidative phosphorylation exploits cancer vulnerability
- (2018) Jennifer R. Molina et al. NATURE MEDICINE
- Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer
- (2018) Yonathan Lissanu Deribe et al. NATURE MEDICINE
- Cx26 drives self-renewal in triple-negative breast cancer via interaction with NANOG and focal adhesion kinase
- (2018) Praveena S. Thiagarajan et al. Nature Communications
- HN1L Promotes Triple-Negative Breast Cancer Stem Cells through LEPR-STAT3 Pathway
- (2018) Yi Liu et al. Stem Cell Reports
- Elucidating the Metabolic Plasticity of Cancer: Mitochondrial Reprogramming and Hybrid Metabolic States
- (2018) Dongya Jia et al. Cells
- Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer
- (2018) Chang-Ching Lin et al. CANCER LETTERS
- Targeting Breast Cancer Stem Cells to Overcome Treatment Resistance
- (2018) Sònia Palomeras et al. MOLECULES
- SOX2 Promotes Cell Proliferation and Metastasis in Triple Negative Breast Cancer
- (2018) Peng Liu et al. Frontiers in Pharmacology
- Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells
- (2018) Jun Tian et al. BRITISH JOURNAL OF CANCER
- Signaling pathway inhibitors target breast cancer stem cells in triple-negative breast cancer
- (2018) Wenlong Li et al. ONCOLOGY REPORTS
- Metabolic reprogramming of oncogene-addicted cancer cells to OXPHOS as a mechanism of drug resistance
- (2018) Jayshree Hirpara et al. Redox Biology
- CBP/β-Catenin/FOXM1 Is a Novel Therapeutic Target in Triple Negative Breast Cancer
- (2018) Alexander Ring et al. Cancers
- Self-renewal signaling pathways in breast cancer stem cells
- (2018) Lakshmi Vineela Nalla et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- STAT3 activation by leptin receptor is essential for TNBC stem cell maintenance
- (2017) Praveena S Thiagarajan et al. ENDOCRINE-RELATED CANCER
- Role of Wnt Co-Receptor LRP6 in Triple Negative Breast Cancer Cell Migration and Invasion
- (2017) Jinlu Ma et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Benserazide, a dopadecarboxylase inhibitor, suppresses tumor growth by targeting hexokinase 2
- (2017) Wei Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia
- (2017) F Peng et al. ONCOGENE
- CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation
- (2017) Heather J. Wright et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions
- (2017) Marc Damelin et al. Science Translational Medicine
- Chemotherapy-Induced Ca 2+ Release Stimulates Breast Cancer Stem Cell Enrichment
- (2017) Haiquan Lu et al. Cell Reports
- MMTV-PyMT and Derived Met-1 Mouse Mammary Tumor Cells as Models for Studying the Role of the Androgen Receptor in Triple-Negative Breast Cancer Progression
- (2017) Jessica L. Christenson et al. Hormones & Cancer
- Wnt signaling in triple-negative breast cancer
- (2017) SÖ-G Pohl et al. Oncogenesis
- Metformin suppresses triple-negative breast cancer stem cells by targeting KLF5 for degradation
- (2017) Peiguo Shi et al. Cell Discovery
- Dasatinib inhibits c-src phosphorylation and prevents the proliferation of Triple-Negative Breast Cancer (TNBC) cells which overexpress Syndecan-Binding Protein (SDCBP)
- (2017) Xiao-Long Qian et al. PLoS One
- Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
- (2017) Wenzhe Li et al. Scientific Reports
- Hallmarks of cancer stem cell metabolism
- (2016) Patricia Sancho et al. BRITISH JOURNAL OF CANCER
- EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape
- (2016) S.-O. Lim et al. CANCER RESEARCH
- UM-164: A Potent c-Src/p38 Kinase Inhibitor with In Vivo Activity against Triple-Negative Breast Cancer
- (2016) R. A. Gilani et al. CLINICAL CANCER RESEARCH
- Small Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma Models
- (2016) Mindy I. Davis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6 ) in breast cancer
- (2016) Gabriele Corda et al. JOURNAL OF PATHOLOGY
- A tyrosine-reactive irreversible inhibitor for glutathione S-transferase Pi (GSTP1)
- (2016) L. A. Crawford et al. Molecular BioSystems
- Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer
- (2016) Roman Camarda et al. NATURE MEDICINE
- Targeting Tumor Mitochondrial Metabolism Overcomes Resistance to Antiangiogenics
- (2016) Paloma Navarro et al. Cell Reports
- Developing and characterization of single chain variable fragment (scFv) antibody against frizzled 7 (Fzd7) receptor
- (2016) Hamid Nickho et al. Bioengineered
- TCF/LEF Transcription Factors: An Update from the Internet Resources
- (2016) Dusan Hrckulak et al. Cancers
- Wnt Signaling in Cancer Stem Cell Biology
- (2016) Felipe de Sousa e Melo et al. Cancers
- Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies
- (2015) A. L. Wong et al. ANNALS OF ONCOLOGY
- Wnt/ -Catenin Small-Molecule Inhibitor CWP232228 Preferentially Inhibits the Growth of Breast Cancer Stem-like Cells
- (2015) G.-B. Jang et al. CANCER RESEARCH
- Treatment of Triple-Negative Breast Cancer with TORC1/2 Inhibitors Sustains a Drug-Resistant and Notch-Dependent Cancer Stem Cell Population
- (2015) Neil E. Bhola et al. CANCER RESEARCH
- Pyruvate dehydrogenase kinase expression and metabolic changes following dichloroacetate exposure in anoxic human colorectal cancer cells
- (2015) Nelson Ho et al. EXPERIMENTAL CELL RESEARCH
- Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP
- (2015) Liangliang Shen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer
- (2015) David Hong et al. Science Translational Medicine
- USP2 promotes cell migration and invasion in triple negative breast cancer cell lines
- (2015) Qing Qu et al. TUMOR BIOLOGY
- Inhibition of STAT3, FAK and Src mediated signaling reduces cancer stem cell load, tumorigenic potential and metastasis in breast cancer
- (2015) Ravi Thakur et al. Scientific Reports
- β-Catenin Is Required for the Tumorigenic Behavior of Triple-Negative Breast Cancer Cells
- (2015) Jinhua Xu et al. PLoS One
- Dichloroacetate, a selective mitochondria-targeting drug for oral squamous cell carcinoma: a metabolic perspective of treatment
- (2015) Vitalba Ruggieri et al. Oncotarget
- Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype
- (2015) Gyu-Beom Jang et al. Scientific Reports
- Enriched CD44+/CD24− population drives the aggressive phenotypes presented in triple-negative breast cancer (TNBC)
- (2014) Fei Ma et al. CANCER LETTERS
- Radiation promotes malignant phenotypes through SRC in breast cancer cells
- (2014) Rae-Kwon Kim et al. CANCER SCIENCE
- Safely targeting cancer stem cells via selective catenin coactivator antagonism
- (2014) Heinz-Josef Lenz et al. CANCER SCIENCE
- Metformin, cancer and glucose metabolism
- (2014) Barbara Salani et al. ENDOCRINE-RELATED CANCER
- Multicentre double-blind randomized controlled trial of perhexiline as a metabolic modulator to augment myocardial protection in patients with left ventricular hypertrophy undergoing cardiac surgery
- (2014) Eshan L. Senanayake et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- The CREB-Binding Protein Inhibitor ICG-001 Suppresses Pancreatic Cancer Growth
- (2014) M. D. Arensman et al. MOLECULAR CANCER THERAPEUTICS
- Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
- (2014) Oscar R. Colegio et al. NATURE
- TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells
- (2014) M Bartucci et al. ONCOGENE
- VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2
- (2014) D Zhao et al. ONCOGENE
- PTK 7 Is a Transforming Gene and Prognostic Marker for Breast Cancer and Nodal Metastasis Involvement
- (2014) Silvia Gärtner et al. PLoS One
- Wnt/Catenin Signaling in Adult Stem Cell Physiology and Disease
- (2014) Alexander Ring et al. Stem Cell Reviews and Reports
- Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment
- (2014) D Ciavardelli et al. Cell Death & Disease
- A novel metformin derivative, HL010183, inhibits proliferation and invasion of triple-negative breast cancer cells
- (2013) Minsoo Koh et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype
- (2013) Peeter Karihtala et al. BREAST CANCER RESEARCH AND TREATMENT
- Loss of FBP1 by Snail-Mediated Repression Provides Metabolic Advantages in Basal-like Breast Cancer
- (2013) Chenfang Dong et al. CANCER CELL
- Stalling the Engine of Resistance: Targeting Cancer Metabolism to Overcome Therapeutic Resistance
- (2013) E. B. Butler et al. CANCER RESEARCH
- Growth of Triple-Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8
- (2013) Z. C. Hartman et al. CANCER RESEARCH
- Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances Tumorigenicity
- (2013) Christine L. Chaffer et al. CELL
- Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells
- (2013) Seog-Young Kim et al. CELLULAR SIGNALLING
- PTK7 modulates Wnt signaling activity via LRP6
- (2013) N. Bin-Nun et al. DEVELOPMENT
- Vimentin as a poor prognostic factor for triple-negative breast cancer
- (2013) Nami Yamashita et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Energy Metabolism Characterization of a Novel Cancer Stem Cell-Like Line 3AB-OS
- (2013) Roberta Palorini et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Tumor-Initiating Cells and FZD8 Play a Major Role in Drug Resistance in Triple-Negative Breast Cancer
- (2013) S. Yin et al. MOLECULAR CANCER THERAPEUTICS
- Paracrine Wnt signaling both promotes and inhibits human breast tumor growth
- (2013) J. L. Green et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PDK1 Signaling Toward PLK1-MYC Activation Confers Oncogenic Transformation, Tumor-Initiating Cell Activation, and Resistance to mTOR-Targeted Therapy
- (2013) J. Tan et al. Cancer Discovery
- Metformin Impairs Glucose Consumption and Survival in Calu-1 Cells by Direct Inhibition of Hexokinase-II
- (2013) Barbara Salani et al. Scientific Reports
- JAK2/STAT5 Inhibition Circumvents Resistance to PI3K/mTOR Blockade: A Rationale for Cotargeting These Pathways in Metastatic Breast Cancer
- (2012) Adrian Britschgi et al. CANCER CELL
- Polo-like Kinase 1: A Potential Therapeutic Option in Combination with Conventional Chemotherapy for the Management of Patients with Triple-Negative Breast Cancer
- (2012) V. Maire et al. CANCER RESEARCH
- MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition
- (2012) Dai Horiuchi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Dysregulated expression of Slug, vimentin, and E-cadherin correlates with poor clinical outcome in patients with basal-like breast cancer
- (2012) Tong Liu et al. JOURNAL OF SURGICAL ONCOLOGY
- Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
- (2012) A. Gurney et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Frizzled and LRP5/6 Receptors for Wnt/ -Catenin Signaling
- (2012) B. T. MacDonald et al. Cold Spring Harbor Perspectives in Biology
- Regulation of embryonic stem cell self-renewal and pluripotency by leukaemia inhibitory factor
- (2011) Hiroyuki Hirai et al. BIOCHEMICAL JOURNAL
- Genetic Predisposition Directs Breast Cancer Phenotype by Dictating Progenitor Cell Fate
- (2011) Theresa A. Proia et al. Cell Stem Cell
- Leptin deficiency suppresses MMTV-Wnt-1 mammary tumor growth in obese mice and abrogates tumor initiating cell survival
- (2011) Q. Zheng et al. ENDOCRINE-RELATED CANCER
- The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors
- (2011) Lauren L.C. Marotta et al. JOURNAL OF CLINICAL INVESTIGATION
- Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype
- (2011) S. Ricardo et al. JOURNAL OF CLINICAL PATHOLOGY
- FZD7 has a critical role in cell proliferation in triple negative breast cancer
- (2011) L Yang et al. ONCOGENE
- The Phenotypic Radiation Resistance of CD44+/CD24−or low Breast Cancer Cells Is Mediated through the Enhanced Activation of ATM Signaling
- (2011) Hong Yin et al. PLoS One
- Deletion of mouse Porcn blocks Wnt ligand secretion and reveals an ectodermal etiology of human focal dermal hypoplasia/Goltz syndrome
- (2011) J. J. Barrott et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Downregulation of CD44 reduces doxorubicin resistance of CD44+CD24- breast cancer cells
- (2011) Pham Van Phuc et al. OncoTargets and Therapy
- Metabolic alterations in cancer cells and therapeutic implications
- (2011) Naima Hammoudi et al. Chinese Journal of Cancer
- Metformin, Independent of AMPK, Inhibits mTORC1 in a Rag GTPase-Dependent Manner
- (2010) Adem Kalender et al. Cell Metabolism
- Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI)
- (2010) Patrick Schöffski et al. EUROPEAN JOURNAL OF CANCER
- β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation
- (2010) Felipe C Geyer et al. MODERN PATHOLOGY
- Ubiquitylation of the amino terminus of Myc by SCFβ-TrCP antagonizes SCFFbw7-mediated turnover
- (2010) Nikita Popov et al. NATURE CELL BIOLOGY
- LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy
- (2010) C.-C. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo
- (2009) Ramon C. Sun et al. BREAST CANCER RESEARCH AND TREATMENT
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- Reciprocal Effects of STAT5 and STAT3 in Breast Cancer
- (2009) S. R. Walker et al. MOLECULAR CANCER RESEARCH
- Wnt signaling activation and mammary gland hyperplasia in MMTV–LRP6 transgenic mice: implication for breast cancer tumorigenesis
- (2009) J Zhang et al. ONCOGENE
- Chemical Probes that Competitively and Selectively Inhibit Stat3 Activation
- (2009) Xuejun Xu et al. PLoS One
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
- (2009) C. J. Creighton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype
- (2008) D. Sarrio et al. CANCER RESEARCH
- Co-overexpression of Janus kinase 2 and signal transducer and activator of transcription 5a promotes differentiation of mammary cancer cells through reversal of epithelial–mesenchymal transition
- (2008) Ahmed S. Sultan et al. CANCER SCIENCE
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Somatic Mutations of ErbB4
- (2008) Denis Tvorogov et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
- SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells
- (2008) A. Vultur et al. MOLECULAR CANCER THERAPEUTICS
- Sensitizing estrogen receptor-negative breast cancer cells to tamoxifen with OSU-03012, a novel celecoxib-derived phosphoinositide-dependent protein kinase-1/Akt signaling inhibitor
- (2008) S.-C. Weng et al. MOLECULAR CANCER THERAPEUTICS
- The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
- (2008) Heather R. Christofk et al. NATURE
- Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition
- (2008) Anne-Pierre Morel et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started